Thymosin Alpha-1
Approved (multiple countries)Thymosin Alpha-1
- Category
- Immune & Inflammatory
- Aliases
- Tα1, Zadaxin, Thymalfasin
- Administration
- Subcutaneous injection
Overview
Thymic peptide that comprehensively modulates immune function. Approved in over 35 countries for viral hepatitis and as an adjunct in cancer therapy. Enhances T-cell development and natural killer cell activity.
Treatments studied
Treatment categories
Cancer (adjunct therapy)
Enhances T-cell and natural killer cell activity, supporting the immune system's response to tumors.
Chronic fatigue
Immune-regulating effects may help address underlying immune dysfunction associated with persistent fatigue.
Hepatitis B
Approved in many countries to enhance the immune response against chronic viral infection.
Hepatitis C
Boosts antiviral immune activity, historically used alongside standard hepatitis C therapies.
Immune deficiency
Directly stimulates T-lymphocyte maturation, strengthening a weakened immune system.
Long COVID
Studied for its potential to help regulate lingering immune dysfunction following viral infection.